Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Kurume Med J ; 69(3.4): 135-142, 2024 May 14.
Article in English | MEDLINE | ID: mdl-38233186

ABSTRACT

Airway stenting involves a stent being inserted into a stenotic site in the airway. In patients with airway stenosis, the airway is the surgical field; therefore, anesthetic management is challenging, and avoiding hypoxia is important. Limited information is available on the anesthetic management of airway stenting. Risk factors for oxygen desaturation during airway stenting remain unknown. The present study was conducted to retrospectively examine patients who underwent airway stenting during a specific period and identify risk factors associated with oxygen desaturation. We performed univariate and multivariate analyses. The main evaluation items in a multivariate analysis were risk factors for desaturation (SpO2 ≤ 90%). Body mass index, preoperative orthopnea, the stenotic site of the airway, and severity of stenosis were selected for clinical usefulness. We analyzed 302 patients who underwent airway stenting at our hospital between July 2011 and June 2014 under general anesthesia with controlled ventilation. Total intravenous anesthesia with propofol target-controlled infusion and remifentanil was performed. Clinical data were extracted from electronic anesthetic records. The incidence of desaturation (SpO2 ≤ 90%) was 18.5% (56 out of 302 cases). Preoperative orthopnea (OR, 3.06)and stenosis distal to the bronchus (OR, 3.31) were identified as risk factors for desaturation in a multivariate analysis. We herein identified risk factors for desaturation during airway stenting. Anesthetic plans need to be carefully considered for patients with these risk factors.


Subject(s)
Stents , Humans , Risk Factors , Male , Female , Stents/adverse effects , Retrospective Studies , Middle Aged , Aged , Anesthesia, General/adverse effects , Airway Obstruction/etiology , Airway Obstruction/diagnosis , Hypoxia/etiology , Adult , Oxygen/blood , Aged, 80 and over , Multivariate Analysis , Oxygen Saturation
2.
J Anesth ; 38(1): 143-144, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37943409
4.
J Anesth ; 37(6): 978, 2023 12.
Article in English | MEDLINE | ID: mdl-37750977
5.
J Anesth ; 37(5): 749-754, 2023 10.
Article in English | MEDLINE | ID: mdl-37561173

ABSTRACT

PURPOSE: This study investigated whether the divided method of multi-level intercostal nerve block (ML-ICB) could reduce the ropivacaine dose required during thoracoscopic pulmonary resection, while maintaining the resting postoperative pain scores. METHODS: This retrospective, single-cohort study enrolled 241 patients who underwent thoracoscopic pulmonary resection for malignant tumors between October 2020 and March 2022 at a cancer hospital in Japan. ML-ICB was performed by surgeons under direct vision. The differences in intraoperative anesthetic use and postoperative pain-related variables at the beginning and end of surgery between group A (single-shot ML-ICB; 0.75% ropivacaine, 20 mL at the end of the surgery) and group B (divided ML-ICB, performed at the beginning and end of surgery; 0.25% ropivacaine, 30 mL total) were assessed. The numerical rating scale (NRS) was used to evaluate pain 1 h and 24 h postoperatively. RESULTS: Intraoperative remifentanil use was significantly lower in group B (14.4 ± 6.4 µg/kg/h) than in group A (16.7 ± 8.4 µg/kg/h) (P = 0.02). The proportion of patients with NRS scores of 0 to 3 at 24 h was significantly higher in group B (85.4%, 106/124) than in group A (73.5%, 86/117) (P = 0.02). The proportion of patients not requiring postoperative intravenous rescue drugs was significantly higher in group B (78.2%, 97/124) than in group A (61.5%, 72/117) (P < 0.01). CONCLUSION: The divided method of ML-ICB could reduce the intraoperative remifentanil dose, decrease the postoperative pain score at 24 h, and curtail postoperative intravenous rescue drug use, despite using half the total ropivacaine dose intraoperatively.


Subject(s)
Anesthetics, Local , Nerve Block , Humans , Ropivacaine , Retrospective Studies , Remifentanil , Intercostal Nerves , Cohort Studies , Nerve Block/methods , Pain, Postoperative/drug therapy , Pain, Postoperative/prevention & control
6.
J Thorac Dis ; 13(6): 3489-3496, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34277044

ABSTRACT

BACKGROUND: Thoracoscopic pulmonary wedge resection (TPWR) is a surgical procedure that can maintain lung function and is less physically invasive to a patient. However, the risk factors for postoperative nausea and vomiting (PONV) following TPWR remain unknown. We aimed to evaluate multiple risk factors of PONV after TPWR and the impact of PONV on postoperative outcomes. METHODS: We retrospectively reviewed consecutive patients who underwent TPWR for malignant pulmonary tumors at our institution between October 2017 and March 2020. We assessed the differences in the clinical and perioperative parameters between the PONV and non-PONV groups. RESULTS: We reviewed 160 patients, of whom 27 (16.9%) had PONV. Sixteen (59.3%) patients with PONV required postoperative antiemetics. Failed mobilization was associated with PONV requiring postoperative antiemetics (P=0.048). In the multivariate analysis, increased fentanyl dose was an independent risk factor for PONV (P=0.022). Using the receiver operating characteristic curve, the optimal cut-off value for PONV was 3.58 µg/kg/hr (area under the curve =0.665; sensitivity =85.2%; specificity =53.4%; 95% confidence interval: 0.562-0.768; P=0.007). For example, in a case of a 50-kg patient who underwent a 70-min operation (our median operative time), the total dose of fentanyl within 208 µg was the cut-off value for preventing PONV. CONCLUSIONS: An increased dose of fentanyl/kg/h was the strongest risk factor for PONV during TPWR. The optimal cut-off value for PONV was 3.58 µg/kg/hr. It is important to avoid the inadvertent administration of intraoperative fentanyl.

7.
Anesth Analg ; 131(3): 893-900, 2020 09.
Article in English | MEDLINE | ID: mdl-31804404

ABSTRACT

BACKGROUND: Airway stenting is a procedure in which a stent is inserted into a stenotic site of the airway. The safest method of ventilation for airway stenting is controversial. A prospective randomized interventional study was conducted on airway stenting. We conducted this study to investigate whether controlled ventilation with muscle relaxants (MR) during airway stenting reduces the incidence of desaturation events (percutaneous oxygen saturation [SpO2] <95%) in comparison with spontaneous respiration (SP). METHODS: Sixty-four patients were enrolled at our hospital between April 2016 and August 2018, and were randomly assigned to the controlled ventilation with MR group or SP group. For anesthesia, total intravenous anesthesia with propofol target-controlled infusion and remifentanil was performed. In the SP group, SP was maintained. In the MR group, a rigid bronchoscope was inserted after the administration of MR to perform controlled ventilation. The incidence of desaturation events was analyzed by logistic regression adjusted by the preoperative respiratory state and stenotic site of the airway. RESULTS: The incidence of desaturation events in the SP and MR groups was 75.0% (24/32) and 9.7% (3/31), respectively, with an odds ratio of 0.04 (95% confidence interval, 0.01-0.16, reference = SP group; P < .001). In the SP group, the mean intraoperative pH was lower than that in the MR group (7.2 ± 0.1 vs 7.4 ± 0.1, respectively; P < .001). In this group, the mean partial pressure of arterial carbon dioxide (PaCO2) was higher (70.2 ± 17.0 mm Hg vs 40.5 ± 8.0 mm Hg, respectively; P < .001) and the mean partial pressure of oxygen in the arterial blood/fraction of the inspiratory oxygen ratio was lower (263.1 ± 64.2 mm Hg vs 396.4 ± 69.4 mm Hg, respectively; P < .001). CONCLUSIONS: Controlled ventilation with MR during airway stenting reduced the incidence of desaturation events, maintaining a favorable respiratory status.


Subject(s)
Airway Obstruction/therapy , Bronchoscopy/instrumentation , Neuromuscular Nondepolarizing Agents/therapeutic use , Respiration, Artificial , Respiration , Rocuronium/therapeutic use , Stents , Aged , Airway Obstruction/diagnosis , Airway Obstruction/physiopathology , Bronchoscopy/adverse effects , Female , Humans , Japan , Male , Middle Aged , Neuromuscular Nondepolarizing Agents/adverse effects , Prospective Studies , Respiration, Artificial/adverse effects , Rocuronium/adverse effects , Treatment Outcome
8.
Kurume Med J ; 64(3): 65-68, 2018 Apr 27.
Article in English | MEDLINE | ID: mdl-29553096

ABSTRACT

Airway stenting is a procedure in which a stent is inserted into a stenotic site in the airway. However, the optimal ventilation for airway stenting remains controversial. We have planned a randomized, unblinded controlled study to compare intraoperative respiratory status by dividing patients, who underwent airway stenting, into spontaneous respiration (SP) and controlled ventilation with muscle relaxants (MR) groups. This study started in April 2016. The subjects, patients aged ≥20 years with airway stenosis caused by malignant neoplasms for which airway stenting was scheduled, are randomly allocated to SP and MR groups. Anesthesia management is performed in accordance with the anesthetic methods established in each group to compare parameters of the intraoperative respiratory status. The primary endpoint is the incidence of intraoperative oxygen desaturation events (SpO2 <95). Secondary endpoints are the mean intraoperative P/F ratio, pH, PaCO2, adverse events, and proportion of protocol treatment achievement. Currently, there is no evidence of anesthetic methods affecting airway stenting. Some studies have claimed that muscle relaxants worsen airway stenosis, while others have reported stable anesthetic management of controlled ventilation with muscle relaxants in airway stenting. This study may aid in clarifying anesthetic methods for airway stenting.


Subject(s)
Airway Obstruction/therapy , Androstanols/therapeutic use , Anesthesia, General/methods , Bronchoscopy/instrumentation , Neoplasms/complications , Neuromuscular Nondepolarizing Agents/therapeutic use , Respiration, Artificial/methods , Respiration , Stents , Airway Obstruction/diagnosis , Airway Obstruction/etiology , Airway Obstruction/physiopathology , Androstanols/adverse effects , Anesthesia, General/adverse effects , Bronchoscopy/adverse effects , Humans , Japan , Neuromuscular Nondepolarizing Agents/adverse effects , Respiration, Artificial/adverse effects , Rocuronium , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...